COMPUGEN LTD (CGEN)

↓ Download CSV

CIK 0001119774 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated L3
  • Fiscal year ends Dec 31

In fiscal 2025, COMPUGEN LTD reported revenue of $72.76M, up 161.1% from the prior year. The company was profitable, with a net margin of 48.6% and a gross margin of 87.3%.

Key ratios (FY2025)

87.3%
Gross margin
43.1%
Operating margin
48.6%
Net margin
34.4%
Return on equity
+161.1%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$72.76M$27.86M$33.46M$7.50M$6.00M$2.00M$17.80M$712.0K
Cost of Revenue$9.25M$7.93M$2.00M$975.0K$680.0K$60.0K$1.03M$223.0K
Gross Profit$63.51M$19.93M$31.45M$6.53M$5.32M$1.94M$16.77M$489.0K
Operating Income$31.33M-$14.89M-$12.99M-$35.37M-$35.07M-$31.50M-$28.88M-$23.23M-$37.41M-$32.58M
Net Income$35.34M-$14.23M-$18.75M-$33.69M-$34.20M-$29.70M-$27.34M-$22.60M-$37.07M-$31.51M
EPS (Diluted)$0.38$-0.16$-0.21$-0.39$-0.41$-0.37$-0.43$-0.41$-0.72$-0.62
Total Assets$156.57M$115.00M$121.33M$94.18M$132.16M$138.32M$53.76M$53.18M$38.75M$71.14M
Shareholders' Equity$102.73M$54.91M$65.56M$77.68M$106.69M$119.78M$38.32M$37.24M$29.30M$63.52M
Cash & Equivalents$90.60M$18.23M$13.89M$11.06M$7.80M$7.14M$9.19M$5.86M$25.47M$9.71M
Operating Cash Flow$31.63M$49.60M-$35.89M-$34.11M-$22.69M-$28.32M-$27.89M-$13.29M-$30.66M-$19.82M
Capital Expenditures$306.0K$118.0K$172.0K$477.0K$292.0K$166.0K$155.0K$158.0K$385.0K$2.60M
Shares Outstanding94.55M89.54M89.24M86.62M86.43M83.68M67.92M59.85M51.29M51.13M